B. Riley starts coverage of QumulusAI with Buy rating and $11 target
B. Riley Securities initiated coverage of QumulusAI with a Buy rating and $11 price target, implying 209% upside from the October 20 close of $3.56.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
B. Riley Securities has initiated coverage of QumulusAI shares with a Buy rating and a price target of $11 per share. According to TradingView, citing data from Benzinga, the target implies a 209% gain from the October 20 close, when the shares traded at $3.56.
The analyst note highlights the company's GPU-as-a-service model. Long-term contracts with up-front prepayments of 17% to 25% give it high revenue visibility, and its signed contract value has grown to $523.4 million.
why it matters
Analysts argue that QumulusAI benefits from speed: it can deliver GPU capacity within three to four months, while traditional data centers take years. For investors this points to demand for computing capacity, but the rating rests on the analysts' forecast rather than confirmed results.
tags
instruments
sources
- B. Riley Securities initiates coverage of QumulusAI with Buy rating, $11 price target — TradingView, 21 October 2026 at 14:35 UTC
- WBB Securities initiates coverage of CytoSorbents with Speculative Buy rating, $9.50 price target — TradingView, 21 October 2026 at 16:15 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗